OA
ANIP icon

OFI Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

OFI Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$27K Buy
689
+8
+1% +$455 ﹤0.01% 1634
2015
Q2 		$42K Sell
681
-165
-20% -$9.82K ﹤0.01% 1594
2015
Q1 		$53K Buy
846
+404
+91% +$24.6K ﹤0.01% 1597
2014
Q4 		$25K Buy
+442
New +$19.5K ﹤0.01% 1660

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OFI Advisors's ANIP Position: Q3 2015 in Review

OFI Advisors increased its ANI Pharmaceuticals (ANIP) stake by 1.2% in Q3 2015, buying an estimated $455 and bringing the position to 689 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

OFI Advisors first reported a position in ANIP in Q4 2014 and has held it in 4 quarters since. The position peaked at $53K in Q1 2015. 121 funds tracked by Wall St. Rank hold ANIP as of Q3 2015.

  • OFI Advisors held 689 shares of ANI Pharmaceuticals worth $27K as of Q3 2015.
  • OFI Advisors bought 8 ANI Pharmaceuticals shares in Q3 2015, an estimated $455.
  • ANI Pharmaceuticals made up ﹤0.01% of OFI Advisors's portfolio in Q3 2015, its #1634 holding.
  • OFI Advisors first reported a position in ANI Pharmaceuticals in Q4 2014 and has held it in 4 quarters since.
  • OFI Advisors's ANI Pharmaceuticals position peaked at $53K in Q1 2015.
  • 121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.